Skip to main content
Have a personal or library account? Click to login
Linkage Analysis by a Transmission/Disequilibrium Test of Russian Sibling Pairs with Coronary Artery Disease Cover

Linkage Analysis by a Transmission/Disequilibrium Test of Russian Sibling Pairs with Coronary Artery Disease

Open Access
|May 2008

References

  1. Buraczynska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska - Czekajska T, Ksiazek A. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.2003; 58(1): 1-9.
  2. Sekuri C, Cam FS, Ercan E, Tengiz I, Sagcan A, Eser E, Berdeli A, Akin M. Renin-angiotensin system gene polymorphisms and premature coronary heart disease.2005; 6(1): 38-42.
  3. Gardemann A, Lohre J, Cayci S, Katz N, Tillmanns H, Haberbosch W. The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile.2002; 160(1): 167-175.
  4. Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study.2003; 41(6): 930-937.
  5. Schneider MP, Erdmann J, Delles C, Fleck E, Regitz-Zagrosek V, Schmieder RE. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase.2000; 18(12): 1767-1773.
  6. Tsai CT, Hwang JJ, Ritchie MD, Moore JH, Chiang FT, Lai LP, Hsu KL, Tseng CD, Lin JL, Tseng YZ. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction.2007; 195(1): 172-180.
  7. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of the angiotensinogen gene to essential hypertension.1994; 330(23): 1629-1633.
  8. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clark AJ. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans.1995; 96(2): 687-692.
  9. Walker WG, Whelton PK, Saito H, Russell RP, Hermann J. Relationship between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects.1979; 1(3): 287-291.
  10. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk.1997; 15(12): 1579-1592.
  11. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.1990; 86(4): 1343-1346.
  12. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.1992; 51(1): 197-205.
  13. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.1992; 359(6396): 641-644.
  14. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.1992; 152(1): 56-64.
  15. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men.1997; 17(1): 107-113.
  16. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study.1988; 8(6): 737-741.
  17. Luciani MF, Denizot F, Savary S, Mattei MG, Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9.1994; 21(1): 150-159.
  18. Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE, Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.1999; 257(1): 29-33.
  19. Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking.2002; 13(4): 373-381.
  20. Schmitz G, Kaminski WE, Orso E. ABC transporters in cellular lipid trafficking.2000; 11(5): 493-501.
  21. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, Brooks-Wilson A, Genest J Jr, Kastelein JJ, Hayden MR. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease.2001; 103(9): 1198-1205.
  22. Pullinger CR, Hakamata H, Duchateau PN, Eng C, Aouizerat BE, Cho MH, Fielding CJ, Kane JP. Analysis of hABC1 gene 5' end: additional peptide sequence, promoter region, and four polymorphisms.2000; 271(2): 451-455.
  23. Cenarro A, Artieda M, Castillo S, Mozas P, Reyes G, Tejedor D, Alonso R, Mata P, Pocovi M, Civeira F, Spanish FH group. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.2003; 40(3): 163-168.
  24. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment.2000; 105(4): 451-458.
  25. Miyahara K, Kawamoto T, Sase K, Yui Y, Toda K, Yang LX, Hattori R, Aoyama T, Yamamoto Y, Doi Y, Ogoshi S, Hashimoto K, Kawai C, Sasayama S, Shizuta Y. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene.1994; 223(3): 719-726.
  26. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK.1999; 100(14): 1515-1520.
  27. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction.1998; 31(7): 1506-1510.
  28. Wang HU, Anderson DJ. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth.1997; 18(3): 383-396.
  29. Winslow JW, Moran P, Valverde J, Shih A, Yuan JQ, Wong SC, Tsai SP, Goddard A, Henzel WJ, Hefti F, Beck KD, Caras IW. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation.1995; 14(5): 973-981.
  30. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.1999; 13(3): 295-306.
  31. Holder N, Klein R. Eph receptors and ephrins: effectors of morphogenesis.1999; 126(10): 2033-2044.
  32. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.1999; 13(9): 1055-1066.
  33. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease.1983; 51(3): 606-607.
  34. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.1972; 18(6): 499-502.
  35. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells.1988; 16(3): 1215.
  36. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test.1998; 62(2): 450-458.
  37. Chiang FT, Lai ZP, Chern TH, Tseng CD, Hsu KL, Lo HM, Tseng YZ. Lack of association between angiotensin-converting enzyme gene polymorphism and coronary heart disease in a Chinese population.1997; 38(2): 227-236.
  38. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites.2000; 20(2): 484-492.
  39. Sun P, Bo XP, Guo DP, Li XY, Hu ZB, Wang J, Li XR, Fan LM, Chen Q. Study on the association of ABCA1 gene common variants with the risk of coronary atherosclerotic heart disease (in Chinese).2005; 33(7): 627-630.
  40. Evans D, Beil FU. The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia.2003; 81(4): 264-270.
  41. Balcerzyk A, Zak I, Krauze J. Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease.2007; 62(3): 233-238.
  42. Rodriguez-Perez JC, Rodriguez-Esparragon F, Hernandez-Perera O, Anabitarte A, Losada A, Medina A, Hernandez E, Fiuza D, Avalos O, Yunis C, Ferrario CM. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective cardiac gene.2001; 37(6): 1536-1542.
  43. Fernández-Arcás N, Dieguez-Lucena JL, Muñoz-Morán E, Ruiz-Galdón M, Espinosa-Caliani S, Aranda-Lara P, Rius-Diaz F, Gaitán-Arroyo MJ, De Teresa-Galván E, Reyes-Engel A. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infaction.2001; 60(1): 52-57.
  44. Tregouet DA, Ricard S, Nicaud V, Arnould I, Soubigou S, Rosier M, Duverger N, Poirier O, Mace S, Kee F, Morrison C, Denefle P, Tiret L, Evans A, Deleuze JF, Cambien F. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction.2004; 24(4): 775-781.
  45. Acarturk E, Attila G, Bozkurt A, Akpinar O, Matyar S, Seydaoglu G. Insertion/deletion polymorphism of the angiotensin converting enzyme gene in coronary artery disease in southern Turkey.2005; 38(4): 486-490.
  46. Buraczynska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska-Czekajska T, Ksiazek A. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.2003; 58(1): 1-9.
  47. Lanz JR, Pereira AC, Lemos PA, Martinez E, Krieger JE. Angiotensinogen M235T polymorphism is associated with coronary artery disease severity.2005; 362(1-2): 176-181.
  48. Nacak M, Davutoglu V, Soydinc S, Dinckal H, Turkmen S, Erbagci B, Akcay M, Aynacioglu S. Association between angiotensin converting enzyme gene polymorphism and coronary artery disease in individuals of the South-Eastern Anatolian population.2004; 4(1): 45-51.
  49. Shi YP, Meng WH, Shan J, Fu GS, Xu G. Polymorphism of angiotensin converting enzyme in Han populations and its relevance to the severity of coronary atherosclerosis (in Chinese).2006; 35(3): 287-291.
  50. The World Health Report 2003e. Geneva, Switzerland: World Health Organization 2003 (
  51. Araujo MA, Goulart LR, Cordeiro ER, Gatti RR, Menezes BS, Lourenco C, Silva HD. Genotypic interactions of renin-angiotensin system genes in myocardial infarction.2005; 103(1): 27-32.
DOI: https://doi.org/10.2478/v10034-008-0006-0 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 43 - 54
Published on: May 30, 2008
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services

© 2008 T Tupitsina, P Slominsky, Y Yufereva, N Perova, D Aronov, S Limborska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.